Importantly, the medication is not an opioid, which means that medical professionals now have an alternative to treating acute pain that doesn’t require using a potentially addictive analgesic.
Hosted on MSN1mon
Xgene’s non-opioid analgesic reduces pain in Phase IIb trialTaiwanese pharmaceutical company Xgene Pharmaceutical announced that its non-opioid analgesic drug XG005 has reduced acute pain in patients after surgery in a Phase IIb study[MV1] . The placebo ...
GlobalData on MSN5d
Allay doses first subject in trial of ATX101 for post-surgical pain reliefAllay Therapeutics has dosed the first subject in the randomised Phase IIb registration trial of its investigational ...
Richard Silverman highlights some of the research that led to the discovery of a novel analgesic drug, while Bob Rappaport discusses his role in the regulation of analgesic drug products.
On Medindia find the complete list of Analgesic And Antipyretic Agent drugs with their available forms and strength. More information is available on each drug including their price list.
VIVOZON Pharmaceutical announced that its non-opioid analgesic, UNAFRA Inj., was approved on December 12, 2024. (active ...
Allay Therapeutics, a clinical-stage biotechnology company pioneering ultra-sustained analgesic products to transform post-surgical pain management an ...
On January 30, the U.S. Food and Drug Administration approved Journavx (suzetrigine) 50 milligram oral tablets, a first-in-class non-opioid ...
Acute and chronic postoperative pain and functional disability persisted among patients who underwent posterior spinal fusion despite multimodal analgesic management.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback